Total patients | Pt. interview cohort | PACE cohort | ||
---|---|---|---|---|
12 | 100% | 2892 | 100% | |
Substance use (high/med.) | ||||
 Any risk | 10 | 83% | 1759 | 61% |
Depression/anxiety | ||||
 PHQ9 (≥ 10) | 4 | 33% | 381 | 13% |
 GAD2 (≥ 3) | 3 | 25% | 378 | 13% |
Demographics | ||||
 Age, median (IQR) | 59 | (41–61) | 55 | (46–62) |
 Sex, n (%) | ||||
  Male | 11 | 92% | 2656 | 92% |
  Female | 1 | 8% | 236 | 8% |
 Risk group, n (%) | ||||
  MSM | 10 | 83% | 2189 | 76% |
  Heterosexual | 2 | 17% | 346 | 12% |
  IV drug use | 0 | 0% | 187 | 6% |
  Other | 0 | 0% | 170 | 6% |
 Race, n (%) | ||||
  White | 6 | 50% | 1532 | 53% |
  Black | 2 | 17% | 535 | 18% |
  Hispanic | 4 | 33% | 474 | 16% |
  Other | 0 | 0% | 351 | 12% |